IntelGenx Corp. Achieves Positive Bioequivalence Results For Erectile Dysfunction Versafilm™ Tadalafil Product
2/24/2014 8:49:13 AM
SAINT LAURENT, Quebec, Feb. 24, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"), a Canadian drug delivery company focusing on oral drug delivery, today announced the completion of a pilot biostudy with its proprietary VersaFilm™ tadalafil product for erectile dysfunction that indicated bioequivalence with the leading brand reference listed drug (RLD) tadalafil product.
Help employers find you! Check out all the jobs and post your resume.
comments powered by